Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

Weifa ASA: New license agreement with AFT Pharmace

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
(Total Views: 409)
Posted On: 01/12/2017 4:45:17 AM
Avatar
Posted By: News Desk 2018
Weifa ASA: New license agreement with AFT Pharmaceuticals for Nordic rights to groundbreaking product line within Pain Management

Weifa has in-licensed a patented fixed-combination product line within pain management from AFT Pharmaceuticals ("AFT") in New Zealand. The agreement gives rights to commercialize the products in the entire Nordic region (Norway, Sweden, Denmark, Finland and Iceland).

The product line consists of a patented fixed ratio of ibuprofen and paracetamol, and covers tablet, sachet and oral liquid formulations. The products are indicated for acute pain and fever conditions, and will be marketed under Weifa's own brand name.

AFT Managing Director, Dr Hartley Atkinson, says "AFT is particularly pleased to expand its existing relationship with Weifa.  Weifa has expertise in the pain management field, as well as in consumer health markets across the Nordic region.  These markets are quite sizable, US$165M 1 , and we look forward to taking substantial market share through our alliance with Weifa. We aim to launch this coming FY2018 time period".

"We are delighted to sign this new alliance agreement with AFT. AFT's product line represents a unique novelty for the Nordic market and will contribute greatly to Weifa's analgesic portfolio.  The success of our Nordic strategy depends on the commercialization of highly innovative products which meet the needs of consumers and pharmacies" says Kathrine Gamborg Andreassen, Chief Executive Officer at Weifa.

About AFT AFT Pharmaceuticals is an Australasian based Pharmaceutical Company listed on the New Zealand and Australian stock exchanges with a market capitalization of circa US$190m. AFT develops pharmaceutical products in the areas of analgesics, treatment of cold & flu, treatment of chronic sinusitis, dermatology and drug delivery.  AFT has a significant local sales presence in Australia and New Zealand with developing sales in Singapore and Malaysia. For further information, please visit: www.aftpharm.com

About Weifa Weifa is Norway's leading consumer health company. We supply real value through medicines, lifestyle products and solutions that address the essential needs of consumers, customers and professional partners. Weifa was founded in 1940 and now employs about 30 highly qualified people at our headquarters in Oslo. The company has a strong position in Norway and is the market leader in pain relief, with well-established brands such as Paracet and Ibux. We are also present in other key areas such as dietary supplements and treatment for colds and respiratory problems. Weifa is listed on the Oslo Børs (ticker WEIFA). For further information, please visit: www.weifa.no

Footnote 1: IMS World Review Pack [Aug 2015] Paracetamol and Ibuprofen tablet market for Nordic countries but excluding Denmark and Iceland]



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us